Cipla Ltd.

Cipla has received approval from the South African and Botswana competition authorities for acquisition of Medpro. However, the implementation of the Scheme is still subject to various other approvals and conditions, including regulatory and government approvals. Earlier on May 15, 2013, the company had received a nod from Shareholders of Cipla Medpro South Africa to acquire 100% stake in the foreign company.

Cipla supplies the bulk of the South African company's drugs through a long-standing agreement; however it has never owned a stake in the Cape Town-based company. This development will give Cipla a direct connect to consumers in South Africa. It also helps the company to integrate its marketing or front-end arm in South Africa with its manufacturing, regulatory and research units.